Drug Shortage Report for ZERIT - CAP 20MG

Last updated on 2019-03-13
Report ID 55662
Drug Identification Number 02216094
Brand name ZERIT - CAP 20MG
Common or Proper name STAVUDINE
Company Name BRISTOL-MYERS SQUIBB CANADA
Active Ingredient(s) STAVUDINE
Strength(s) 20MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1 BTL x 60
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-03-25
Actual start date
Estimated end date 2019-03-25
Actual end date
Shortage status Anticipated shortage
Updated date 2019-03-13
Company comments Product on allocation
Health Canada comments
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
MONTRÉAL (ST-LAURENT), QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005